Biosite Diagnostics Launches Coronary Collaboration

Incorporated has announced the launch of a collaborative Biosite Discovery program to identify novel proteins that can advance care for patients with acute coronary syndrome, or ischemic heart disease, the most common cause of death worldwide.

The collaboration leverages Biosite’s existing partnership with and introduces new clinical collaborators, including the Thrombolysis In Myocardial Infarction (TIMI) Study Group, an investigation team that has been at the forefront of clinical research in acute coronary syndromes over the past two decades.

“We urgently need more accurate tests for the diagnosis and risk stratification of acute coronary syndrome in order to improve prospects for the millions of patients who visit emergency departments each year with chest pain of unknown cause,” said Dr. Eugene Braunwald, chairman of the TIMI Trials.

“We hope that this collaboration will speed the development of such tests.”

Under the terms of the collaboration, Biosite Discovery would continue its ongoing evaluation of at least 30 known markers, using its Omniclonal phage display technology to perform research and assay development.

Biosite would analyse markers for diagnostic utility using clinical samples provided by the TIMI Study Group, among others.

Clinical samples would also be provided to Large Scale Proteomics, which would apply its proteomics technology for protein target discovery.

Large Scale Proteomics would conduct further research on promising targets and would also send these to Biosite for diagnostic evaluation.

As part of the agreement, Biosite would provide Large Scale Proteomics with Omniclonal antibody services to aid in their research.

is a leading provider of proteomic technologies to the life sciences industry and is located in Rockville, Md. The TIMI Study Group organized in 1984 and led by Dr. Eugene Braunwald of Brigham and Women’s Hospital in Boston, Mass., is committed to advancing the knowledge and care of patients suffering from acute coronary syndromes by performing clinical research.

Incorporated is dedicated to meeting important clinical needs in emergency medicine by speeding the flow of critical diagnostic information.

Through its integrated discovery and diagnostics businesses, Biosite seeks to develop rapid diagnostic tests that improve clinical and economic outcomes for acute diseases.

Procure Dragon Pharma Safely

Propionat 100

Injectable Anabolic Steroid
Principal Chemical Name: Testosterone Propionate
Made by: Dragon Pharmaceutical
Amount: 1 X 10 ml (100 mg/ml)

Dianabol 20 - Bulk Price

Administration: Oral
Basic Ingredient: Methandrostenolone
Branded by: Dragon Pharma LLC
Pack: 10 x 100 pastilles (20 mg/tablet)
Price: 10 x $39.00

Deca 300 - Cheap Price

Administration: Injection
Basal Constituent: Nandrolone Decanoate
Producer: Dragon Pharma LLC
Unit: 20 x 10 mL vial (300 mg/mL)
Price: 20 x $37.00

Primobolan 100

Injectable Anabolic Steroid
Base Chemical Name: Methenolone Enanthate
Producer: Dragon Pharmaceuticals
Unit: 1 X 10 ml (100 mg/ml)

Clenbuterol - Bulk Price

Administration: Oral
Basic Substance: Clenbuterol Hydrochloride
Produced by: Dragon Pharma
Amount: 10 x 100 tabs (40 mcg/tab)
Price: 10 x $25.00

Trenbolone 100 - Cheap Price

Administration: Injection
Base Chemical Name: Trenbolone Acetate
Made by: Dragon Pharma LLC
Unit: 20 x 10 mL vial (100 mg/mL)
Price: 20 x $52.00

EQ 300 - Bulk Price

Administration: Injection
Basic Ingredient: Boldenone Undecylenate
Manufacturer: Dragon Pharma LLC
Unit: 10 x 10 mL vial (300 mg/mL)
Price: 10 x $42.00

Trenbolone 50

Injectable Steroid for Muscle Growth
Main Ingredient: Trenbolone Suspension
Manufacturer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (50 mg/mL)

EQ 500

Injectable Steroid for Muscle Growth
Basic Substance: Boldenone Undecylenate
Branded by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (500 mg/mL)

EQ 300

Principal Substance: Boldenone Undecylenate
Produced by: Dragon Pharmaceuticals
Pack: 10 mL vial (300 mg/mL)

NPP 150

Basal Substance: Nandrolone Phenylpropionate
Made by: Dragon Pharma LLC
Package: 10 x 10 mL vial (150 mg/mL)

Trenbolone 200

Primary Ingredient: Trenbolone Enanthate
Producer: Dragon Pharmaceuticals
Amount: 10 x 10 mL vial (200 mg/mL)